Arterial expression of the plasminogen activator system early after cardiac transplantation.
OBJECTIVE
Recent studies suggest that alterations in tissue thrombolysis as well as the inward migration of cells may be specific events that contribute to coronary artery narrowing after cardiac transplantation. Plasminogen activators and inhibitors play a central role in governing not only tissue thrombolysis, but also vascular cell migration. The purpose of this study was to examine arterial wall expression of the plasminogen activation system in coronary arteries during graft vascular disease initiation and progression.


METHODS
Using in situ hybridization and immunocytochemistry, the expression patterns of uPA and PAI-1 in coronary arteries from cardiac allografts were compared to those of young individuals without disease.


RESULTS
Both PAI-1 and uPA were over-expressed early after transplantation and as late as 27 months post grafting. Over-expression of these molecules preceded morphological evidence of graft vascular disease. Of special note was the adventitial expression of uPA and PAI-1 in microvessels and myofibroblasts. In contrast, the expression of uPA and PAI-1 in normal coronary arteries was confined to endothelial cells of the central lumen, as well as low levels of expression in intimal and medial smooth muscle cells.


CONCLUSIONS
Despite morphologic similarities between normal and transplant coronary arteries, differences were noted in the vascular expression pattern of uPA and PAI-1. The exact role of these molecules in graft vascular disease requires further study; however, it is intriguing to consider that a local imbalance in the plasminogen system may contribute to arterial wall thrombosis and/or excessive cell migration and the genesis of complex vascular lesions.
Garvin
M R
MR
Department of Medicine (Cardiology), University of Ottawa Heart Institute, Ont., Canada.
Labinaz
M
M
Pels
K
K
Walley
V M
VM
Mizgala
H F
HF
O'Brien
E R
ER
D000293:Adolescent; D000328:Adult; D003327:Coronary Disease / Q000378:metabolism*; D003331:Coronary Vessels / Q000737:chemistry* / Q000201:enzymology; D015870:Gene Expression; D006086:Graft vs Host Disease / Q000209:etiology* / Q000378:metabolism; D016027:Heart Transplantation; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008297:Male; D017395:Plasminogen Activator Inhibitor 1 / Q000032:analysis* / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000032:analysis* / Q000235:genetics
D017395:Plasminogen Activator Inhibitor 1; D012333:RNA, Messenger; D014568:Urokinase-Type Plasminogen Activator